 14. She, Q.B., et al., Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3-kinaseAkt pathway signaling. Clin Cancer Res, 2003. 912: p. 4340-6. 